Inghams Group Limited (ASX:ING)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Jun 29, 2024	Jun 24, 2023	Jun 25, 2022	Jun 26, 2021	Jun 27, 2020
Market Capitalization	1,256	1,345	985	974	1,483	1,189
Market Cap Growth	-20.10%	36.60%	1.15%	-34.34%	24.69%	-20.40%
Enterprise Value	2,742	3,134	2,775	2,809	3,362	3,222
Last Close Price	3.38	3.41	2.34	2.28	3.32	2.55
PE Ratio	14.08	13.26	16.31	27.74	17.80	29.66
Forward PE	11.91	11.43	13.03	12.93	16.35	13.85
PS Ratio	0.39	0.41	0.32	0.36	0.56	0.47
PB Ratio	5.26	6.13	4.88	6.16	9.07	9.21
P/TBV Ratio	5.55	6.13	4.88	6.16	9.07	9.21
P/FCF Ratio	4.23	5.24	3.43	3.48	3.97	4.61
P/OCF Ratio	3.28	3.22	2.74	2.85	3.37	3.45
PEG Ratio	3.87	0.45	0.42	0.93	1.18	-
EV/Sales Ratio	0.85	0.96	0.91	1.03	1.26	1.26
EV/EBITDA Ratio	8.24	11.18	13.60	18.09	14.30	18.04
EV/EBIT Ratio	13.37	13.87	18.51	28.26	18.81	26.05
EV/FCF Ratio	9.23	12.20	9.66	10.04	9.00	12.50
Debt / Equity Ratio	6.93	7.86	9.41	12.29	11.88	15.88
Debt / EBITDA Ratio	4.99	3.67	4.54	5.25	4.38	5.30
Debt / FCF Ratio	5.57	6.72	6.62	6.95	5.20	7.95
Asset Turnover	1.30	1.31	1.19	1.07	1.04	1.40
Inventory Turnover	11.20	11.53	11.03	10.62	10.56	11.06
Quick Ratio	0.71	0.49	0.56	0.48	0.54	0.50
Current Ratio	1.29	1.08	1.10	1.00	1.00	1.03
Return on Equity (ROE)	38.61%	48.17%	33.56%	21.82%	56.92%	27.32%
Return on Assets (ROA)	5.14%	5.68%	3.66%	2.44%	4.37%	4.23%
Return on Capital (ROIC)	6.38%	6.98%	4.46%	2.95%	5.21%	5.44%
Return on Capital Employed (ROCE)	11.90%	13.20%	8.10%	5.50%	9.70%	6.50%
Earnings Yield	7.13%	7.54%	6.13%	3.60%	5.62%	3.37%
FCF Yield	23.65%	19.09%	29.15%	28.72%	25.19%	21.68%
Dividend Yield	5.62%	5.87%	6.19%	3.07%	4.97%	5.49%
Payout Ratio	82.92%	80.59%	30.80%	164.10%	63.39%	164.84%
Buyback Yield / Dilution	-0.35%	-0.21%	-0.00%	-0.08%	-0.11%	2.00%
Total Shareholder Return	5.28%	5.66%	6.19%	2.99%	4.86%	7.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.